Click here for Analysts' Upgrades, Downgrades.Editor's Note: Green and red arrows refer to intraday stock price movement. NEW YORK ( TheStreet) -- AmerisourceBergen ( ABC - Get Report) added to Conviction Buy List at Goldman. Company has good earnings visibility over the next couple of years. Agco ( AGCO - Get Report) estimates, target upped at Goldman. AGCO estimates were boosted through 2012. Visibility is improving for demand in Western Europe. Buy rating and new $55 price target. Allegiant Travel ( ALGT - Get Report) price target cut at Barclays to $59 from $61. Investing in ALGT is risky, outlook uncertain, Barclays said. Maintain Overweight rating. Applied Materials ( AMAT) target, estimates higher at Credit Suisse. AMAT price target raised by a dollar to $15. Strong sector view, Credit Suisse said. 2010 and 2011 EPS estimates raised to $0.87 and $1.25, respectively. Maintain Neutral rating. Darden Restaurants ( DRI - Get Report) target boosted at Oppenheimer to $57. Company is likely seeing higher sales, especially at Red Lobster. Edwards Lifesciences ( EW - Get Report) price target higher at Barclays to $80 from $75. Building out commercial infrastructure ahead of the potentially significant Sapien launch, Barclays said. Maintain Overweight rating. Health Management Associates ( HMA) price target boosted at Barclays by a dollar to $11. HMA has shown continued signs of progress with better-than-expected revenue growth, Barclays said. Maintain Overweight rating. US Airways Group ( LCC) price target raised at Barclays by a dollar to $15. Supply and demand balance in the industry will improve in the coming years, Barclays said. Maintain Equal Weight rating. Novellus Systems ( NVLS) target, estimate boosted at Barclays to $43 from $35 on stronger growth, Credit Suisse said. 2011 and 2012 EPS estimates increased to $3.56 and $3.69, respectively. Maintain Outperform rating. Occidental Petroleum ( OXY) target increased at Oppenheimer. OXY target was raised to $105, Oppenheimer said. Company recently boosted its dividend and should continue to generate steady cash flow. Pioneer Natural ( PXD) target raised at Oppenheimer. Shares of PXD now seen reaching $96, according to Oppenheimer. Company can continue to outperform its peers, despite lower energy prices. Tesoro ( TSO) price target raised at Barclays. TSO price target increased to $20 from $16 after positive meeting with management, Barclays said. Maintain Equal Weight rating.
More from Stocks
Microsoft Gains on Solid Results and Guidance: 10 Key Takeaways
The software giant beat estimates with the help of strong corporate demand for a number of different products and services. And it struck an upbeat tone about the upcoming fiscal year.
Replay: Jim Cramer on Netflix's Earnings, and His Three Keys for Earnings Season
Jim Cramer breaks down what investors need to know when it comes to Netflix, earnings season and how he's looking at the markets.
Amazon Prime Day Sales Topped $7 Billion: Internet Retailer
An early analysis by Internet Retailer estimates that Amazon's 48-hour Prime Day event hit $7.16 billion in sales, surpassing an earlier estimate of more than $6 billion.
Combative Hearings for Facebook's Libra Suggest Project Could Face Long Delays
After the contentious series of hearings, Rep. Maxine Waters and others said that Facebook CEO Mark Zuckerberg should be called to testify on plans for the cryptocurrency.
The 3 Things Jim Cramer Must See Before He'll Buy An Expensive Stock
Anything with a high P/E must have a large total addressable market, the ability to scale up its business and a wide 'moat.' One stock that fits the bill: Mastercard.